This Study Aims to Evaluate the Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Properties and Food Effect of IN-114199 in Healthy Participants
Phase 1
Not yet recruiting
- Conditions
- Chronic Idiopathic Constipation
- Interventions
- Drug: IN-114199 10mg or placeboDrug: IN-114199 20mg or placeboDrug: IN-114199 2.5mg or placeboDrug: IN-114199 5mg or placeboDrug: IN-114199 40mg or placebo
- First Posted Date
- 2024-12-17
- Last Posted Date
- 2024-12-17
- Lead Sponsor
- HK inno.N Corporation
- Target Recruit Count
- 80
- Registration Number
- NCT06736912
- Locations
- 🇰🇷
Seoul National University Hospital, Clinical Trial Center, Seoul, Korea, Republic of
To Compare the Pharmacokinetics and Safety After a Single Dose Administration of IN-G00002 and IN-R00002 in Healthy Adult Volunteers
Phase 1
Active, not recruiting
- Conditions
- Non-valvular Atrial Fibrillation (NVAF)
- Interventions
- Drug: IN-G00002
- First Posted Date
- 2024-12-10
- Last Posted Date
- 2024-12-10
- Lead Sponsor
- HK inno.N Corporation
- Target Recruit Count
- 60
- Registration Number
- NCT06725355
- Locations
- 🇰🇷
Central Hospital, Clinical Trial Center, Siheung, Korea, Republic of
Long-term Observational Study to Evaluate the DFS and OS of Adjuvant FOLFIRINOX Regimen in Pancreatic Cancer Patients
Recruiting
- Conditions
- Adjuvant Chemotherapy
- First Posted Date
- 2024-04-29
- Last Posted Date
- 2024-04-29
- Lead Sponsor
- HK inno.N Corporation
- Target Recruit Count
- 36
- Registration Number
- NCT06389552
- Locations
- 🇰🇷
Seoul ST. Mary's Hospital, Seoul, Korea, Republic of
PK, PD and Safety of Tegoprazan 12.5 mg After Oral Administration in Healthy Subjects
Phase 1
- Conditions
- Healthy
- Interventions
- First Posted Date
- 2024-03-27
- Last Posted Date
- 2024-03-27
- Lead Sponsor
- HK inno.N Corporation
- Target Recruit Count
- 36
- Registration Number
- NCT06332638
- Locations
- 🇰🇷
Inje University Busan Paik Hospital, Busan, Korea, Republic of
Effect of Tegoprazan on Pharmacodynamics of Clopidogrel in Healthy Subjects
Phase 1
Not yet recruiting
- Conditions
- Healthy
- Interventions
- First Posted Date
- 2023-12-11
- Last Posted Date
- 2023-12-11
- Lead Sponsor
- HK inno.N Corporation
- Target Recruit Count
- 48
- Registration Number
- NCT06164834
- Locations
- 🇰🇷
Seoul National University Hospital, Clinical Trial Center, Seoul, Korea, Republic of
Exploratory Study to Standard Triple Therapy With Tegoprazan(by Dose) in H. Pylori Positive Patients
Phase 2
Recruiting
- Conditions
- Helicobacter Pylori Infection
- Interventions
- First Posted Date
- 2023-07-06
- Last Posted Date
- 2023-07-06
- Lead Sponsor
- HK inno.N Corporation
- Target Recruit Count
- 381
- Registration Number
- NCT05933031
- Locations
- 🇰🇷
Chung-Ang University Hosptial, Seoul, Korea, Republic of
A Study to Evaluate the Safety, Tolerability and Pharmacokinetic Properties of IN-A002 Ointment in Healthy Adult Male Volunteers and Mild to Moderate Atopic Dermatitis Patients
Phase 1
Not yet recruiting
- Conditions
- Mild to Moderate Atopic Dermatitis
- Interventions
- Drug: IN-A002 Ointment 0.5% or IN-A002 Placebo OintmentDrug: IN-A002 Ointment 1% or IN-A002 Placebo OintmentDrug: IN-A002 Ointment 3%Drug: IN-A002 Ointment 0.3% or IN-A002 Placebo OintmentDrug: IN-A002 Ointment 3% or IN-A002 Placebo OintmentDrug: IN-A002 Ointment 5% or IN-A002 Placebo OintmentDrug: IN-A002 Ointment 1%
- First Posted Date
- 2023-02-15
- Last Posted Date
- 2023-02-15
- Lead Sponsor
- HK inno.N Corporation
- Target Recruit Count
- 80
- Registration Number
- NCT05729074
PK and PD Interaction Between Tegoprazan and NOACs After Multiple Oral Dosing in Healthy Volunteers
Phase 1
Completed
- Conditions
- Healthy
- Interventions
- First Posted Date
- 2023-02-10
- Last Posted Date
- 2023-12-11
- Lead Sponsor
- HK inno.N Corporation
- Target Recruit Count
- 87
- Registration Number
- NCT05723510
- Locations
- 🇰🇷
Jeonbuk National University Hospital, Jeonju, Korea, Republic of
A Study to Evaluate the Efficacy and Safety of Tegoprazan in GERD Patients With Nighttime Heartburn
Phase 4
Recruiting
- Conditions
- Gastroesophageal Reflux Disease
- Interventions
- First Posted Date
- 2023-01-27
- Last Posted Date
- 2023-08-03
- Lead Sponsor
- HK inno.N Corporation
- Target Recruit Count
- 338
- Registration Number
- NCT05701540
- Locations
- 🇰🇷
Severance Hospital, Seoul, Korea, Republic of
A Study to Evaluate Effect of IN-A001 on Pharmacokinetics of Tacrolimus in Healthy Volunteers
Phase 1
- Conditions
- Healthy
- Interventions
- First Posted Date
- 2022-04-29
- Last Posted Date
- 2022-04-29
- Lead Sponsor
- HK inno.N Corporation
- Target Recruit Count
- 12
- Registration Number
- NCT05353010
- Locations
- 🇰🇷
Asan Medical Center, Seoul, Korea, Republic of